ARL2BPP1

Across TCGA pan-cancer cohorts, ARL2BPP1 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated ARL2BPP1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher ARL2BPP1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ARL2BPP1 expression acts as an unfavorable survival marker.

KIRC, ACC, and STAD are the cancer types where ARL2BPP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.455	0.656	<.001	150	view →
ACC	OS	Tertile	All	0.133	0.686	.004	72	view →
STAD	OS	Tertile	All	0.469	0.757	.001	45	view →
SARC	OS	Tertile	All	0.199	0.620	<.001	21	view →
LUSC	OS	Tertile	All	0.350	0.727	.028	18	view →
BRCA	OS	Tertile	All	0.831	0.927	.011	18	view →
TGCT	OS	Tertile	All	0.867	0.967	.040	18	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

ARL2BPP1–KIRC (OS)

Open the KIRC breakdown →